SG Americas Securities, LLC

Broker-Dealer

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1313360 NEW YORK, NY

Position in CTMX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$138,236

-$88,008 QoQ

Shares Held

36,863

-30.6% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#111

of 178 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. CTMX ranks #146 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	427,703	$266,689,928
2	VRTX	Vertex Pharmaceuticals Inc / Ma	523,720	$260,147,435
3	URGN	UroGen Pharma Ltd.	2,052,906	$75,546,940
4	CGON	CG Oncology, Inc.	867,465	$61,633,388
5	PTCT	Ptc Therapeutics, Inc.	605,581	$49,397,242
6	ASND	Ascendis Pharma A/S	161,026	$42,948,854
7	RPRX	Royalty Pharma plc	688,590	$38,609,241
8	BNTX	BioNTech SE	347,131	$32,300,539

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$138,236	36,863	-30.6%	Shares	Sole	2026-08-07
2025-12-31	$226,244	53,109	+103.4%	Shares	Sole	2026-01-09
2024-03-31	$56,928	26,114	+79.7%	Shares	Sole	2024-05-06
2022-03-31	$38,795	14,530	+42.3%	Shares	Sole	2022-04-29
2021-12-31	$44,204	10,209	-66.9%	Shares	Sole	2022-02-07
2021-09-30	$157,006	30,846	+166.5%	Shares	Sole	2021-11-01
2021-06-30	$73,263	11,574	-14.1%	Shares	Sole	2021-08-12
2021-03-31	$104,169	13,476	-38.2%	Shares	Sole	2021-05-13
2020-09-30	$144,950	21,797	+80.2%	Shares	Sole	2020-11-09
2020-06-30	$100,776	12,098	-30.3%	Shares	Sole	2020-07-20
2020-03-31	$133,112	17,355	—	Shares	Sole	2020-04-30
No filing history on record for this holder in this stock.